NHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
National Healthcare Corp (NHC) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. While the company has demonstrated strong financial performance in the latest quarter, the technical indicators and options data do not suggest a compelling entry point. Additionally, there are no significant positive catalysts or trading signals to justify immediate action.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating a positive long-term trend. However, the MACD histogram is negative (-0.328), and RSI is neutral at 58.78, showing no clear momentum. The price is near a resistance level (R1: 164.209), which may limit short-term upside potential.
The company's financial performance in Q4 2025 was impressive, with revenue increasing by 4.65% YoY, net income surging by 308.63% YoY, and EPS growing by 305.13% YoY. Gross margin also improved to 36.61%, up 9.41% YoY.
No recent news or significant trading trends from hedge funds, insiders, or Congress. The MACD and RSI do not indicate strong momentum, and the stock is close to a resistance level, which may limit immediate upside.
In Q4 2025, NHC demonstrated strong growth with revenue of $386.51M (+4.65% YoY), net income of $24.85M (+308.63% YoY), and EPS of 1.58 (+305.13% YoY). Gross margin improved to 36.61% (+9.41% YoY), reflecting strong operational performance.
No recent analyst ratings or price target changes are available for this stock.
